1. Home
  2. ENSC vs INBS Comparison

ENSC vs INBS Comparison

Compare ENSC & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$1.26

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$0.55

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENSC
INBS
Founded
2003
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ENSC
INBS
Price
$1.26
$0.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
417.4K
148.5K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,487,973.00
$3,292,042.00
Revenue This Year
N/A
$778.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.51
3.26
52 Week Low
$1.26
$0.56
52 Week High
$10.96
$2.75

Technical Indicators

Market Signals
Indicator
ENSC
INBS
Relative Strength Index (RSI) 28.90 28.68
Support Level $1.26 $0.68
Resistance Level $1.69 $0.73
Average True Range (ATR) 0.15 0.05
MACD -0.02 0.00
Stochastic Oscillator 4.84 5.41

Price Performance

Historical Comparison
ENSC
INBS

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: